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Abstract 
 
Objectives: Suspected cerebrospinal fluid shunt (CSF) dysfunction in hydrocephalic 
patients poses a diagnostic uncertainty. The clinical picture can be nonspecific and CT 
imaging alone is not always pathognomic. Infusion tests are an increasingly used 
investigation for real-time hydrodynamic assessment of shunt patency. We report 
correlation between infusion test results with quality of ventricular drain  placement 
on CT image in large retrospective group of hydrocephalic patients. 
Materials & methods: 306 infusion test results performed in 200 patients were 
correlated with 306 corresponding CT head scans. Nominal logistic regression was 
used to correlate shunt catheter position on imaging to patency of ventricular drain as 
determined by infusion tests. 
Results: Infusion test results of shunt patency are statistically congruent with the 
analysis of shunt catheter position on CT head scans. Catheter tips completely 
surrounded by either parenchyma or CSF on CT imaging, are strongly associated with 
evidence of occlusion or patency from infusion tests, respectively (χ²=51.68, 
p<0.0001, n=306 and χ²=31.04, p <0.0001, n=306).  
Conclusions: The most important anatomical factor for shunt patency is the catheter 
tip being completely surrounded by CSF. Infusion tests provide functional and 
reliable assessment of shunt patency in vivo and is strongly correlated with the 
position of the ventricular catheter on CT imaging.  
 
Keywords: Infusion test, ventriculoperitoneal shunts, hydrocephalus
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Introduction 
Only modest progress has been made in preventing ventriculo-peritoneal shunt failure 
for several decades
1
. Shunt revision is still a common neurosurgical operation, posing 
significant risks to patients and a heavy financial burden on healthcare services
2
. 
Recent long-term studies have quoted shunt failure rates requiring revision surgery of 
23%
3
 and 46%
4
 over 8 years. Mechanical dysfunction accounts for 74% of such 
revisions
3
 with occlusion of the proximal catheter being the most common site for 
obstruction
5
. 
 
Electron microscopic and histological evidence from blocked ventricular and 
peritoneal catheters show that the cause of occlusion is often debris from choroid 
plexus and ependyma
6,7
. Therefore it has been suggested that the optimal position for 
the tip of the ventricular catheter ought to be in the ipsilateral frontal horn anterior to 
the foramen of Monro
8-10
, since the choroid plexus is absent from this part of the 
ventricle.  
 
Since Albright and colleagues quoted only 55% of the frontally placed catheters were 
in ‘good’ position in 1988
11, 
with functional shunt survival related to positioning, 
more recent studies still quote high risk of sub-optimally placed frontal catheters; up 
to 56%
12
. This is in part likely due to the fact that the freehand ventriculostomy has 
traditionally been undertaken as a ‘blind’ procedure, relying on surface anatomical 
landmarks to guide insertion. This notion is supported by studies of other procedures 
requiring ‘blind’ ventriculostomy such as external ventricular drain insertion which 
also show high incidence of suboptimal ventricular catheter positioning
13,14
. 
Unsurprisingly, this has led to a shift towards using image guidance or other tools to 
aid in improving the accuracy of ventricular cannulation
12,15
. 
 
Many studies investigating shunt dysfunction have used the clinical assessment of 
patients, the decision to revise a shunt and Computed Tomography (CT) imaging to 
assess catheter position and changes in ventricular size as surrogate markers to infer 
the patency of shunts
1,3,4,7
. Increasingly in clinical practice, infusion tests are being 
undertaken as a means to be objectively measure the flow dynamics of fluid within 
shunts in vivo
16-19
, especially when the diagnosis of shunt dysfunction is not clearly 
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evident from the clinical presentation and changes in ventricular size on CT alone, 
which may never happen in normal pressure hydrocephalus (NPH). When infusion 
test technique may be seen as little bit outdated, and new theories for development of 
hydrocephalus are proposed
20
, using of infusion test to scrutinize shunt performance 
in vivo seems to be clinically well-funded.
21
  
 
 
In this study, we investigate the relationship between ventricular catheter position on 
CT scans using an objective classification and their effect on patency of shunt’s 
system ventricular drain as assessed by infusion tests. The study was conducted 
retrospectively in prospective patients with symptoms of shunt dysfunction where the 
diagnosis was ambiguous (i.e. patients were not just revised based on imaging and 
clinical symptoms, but referred by consultant neurosurgeon in charge to 
Hydrocephalus Clinic, to conduct infusion test). 
 
Matherial and Methods 
A retrospective, non-controlled, observational prospective cohort was studied. All 
data used was derived from clinical records of patients at Addenbrookes Hospital, 
Cambridge University Hospitals NHS Trust. Due to the use of retrospective historical 
records and no active patient involvement during the data collection, patient consent 
for the use of data in research was taken pre-emptively by Addenbrooke’s Hospital, 
Cambridge University Hospitals NHS Trust as part of routine audit protocol. Patients 
who had an infusion test on the basis of clinical symptoms of ventriculo-peritoneal 
shunt dysfunction between 2007 and 2011 were identified. The results of their 
infusion tests were analysed and classified according to the state of ventricular drain - 
either obstructed or patent (see descriptions below).  
 
To correlate these physiological evaluations of shunt patency with the anatomical 
position of the proximal catheter tips, we analysed the CT head scans for the same 
patients within this period using a new classification system. We excluded scans with 
a greater than three month interval between scan and infusion test, and any patients 
that had revision operations within this time to ensure that the same shunt proximal 
catheter was being assessed physiologically by infusion test and radiologically by CT 
Page 4 of 24
Acta Neurologica Scandinavica - PROOF
Acta Neurologica Scandinavica - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
PROOF
scan. Data from both the physiological and radiological assessments were correlated 
statistically.  
 
Infusion test and its analysis 
The infusion test is a technique, modified from the “Constant-Infusion Manometric 
Test” described by Katzman and Hussey
22
. It involves the insertion of two 25G 
butterfly needles into the subcutaneous shunt reservoir, which is connected with the 
intra-ventricular catheter. Via one needle, saline is infused at a constant rate, whilst 
the other records pressure changes (Fig 1 upper panel). During the infusion, the 
computer calculates and presents mean pressure and pulse amplitude [with time along 
the x axis (see Figure 1 lower panel)]. Pressure increases slowly, as a compliance of 
CSF space is substantial and pulse amplitude of pressure waveform usually increases 
proportionally to pressure. The resistance to CSF outflow can be calculated using 
simple arithmetic as the difference between the value of the plateau pressure during 
infusion and the resting pressure divided by the infusion rate. Repeatability of 
calculation of the resistance to CSF outflow has been investigated before
23
.  However, 
the precise measurement of the final pressure plateau is not possible when strong 
vasogenic waves arise or an excessive elevation of the pressure above the safe limit of 
40 mm Hg is recorded. Computerized analysis produces results even in difficult cases 
when the infusion is terminated prematurely. The algorithm utilizes time series 
analysis for volume-pressure curve retrieval, the least-mean-square model fitting and 
an examination of the relationship between the  pulse amplitude and the mean CSF 
pressure. The pressure-volume curve is investigated. 
Infusion test does not need special technical assistance. Recording lasts on average 30 
minutes. Risk of infection is limited to less than 1% according to internal audit.  It is 
helpful if it is supported by specialized software like computer program (Intensive 
Care Monitor (ICM+), Cambridge Enterprise Limited)
24
 which processes the recorded 
data to provide graphical waveforms of intracranial pressure, heart rate and pulse 
amplitude derived from intracranial pressure fluctuations whilst saline is being 
infused. Infusion tests have been shown to provide an objective evaluation of shunt 
function in vivo
16-18
 with satisfactory (90%) positive predictive power
16,21
. 
All infusion tests performed in patients with suspected non-functioning ventriculo-
peritoneal shunts at Addenbrooke’s Hospital between 2007 and 2011 were assessed. 
499 infusion tests met the inclusion criteria above. 
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With these objective measurements, infusion tests can distinguish between shunts that 
are: 
1. functional, 
2. high opening pressure but not indicative of obstruction, i.e. calculated outflow 
resistance in agreement with nominal resistance of opened shunt, indicating 
increased abdominal pressure, 
3. obstructed – distal
21,25
, 
4. obstructed – proximal. 
For the purposes of this study we classified groups 1, 2 and  3 above as shunts with 
patent ventricular drain and group 4 as obstructed. 
 
Each group has a distinct pattern on the pressure waveform produced during the 
infusion test. In the following two figures the differences between functional and a 
proximally obstructed shunt are demonstrated.  
 
In Figure 2, three essential features consistent with correct functioning ventricular end 
of shunt system are illustrated. Firstly, the normal baseline intra-cranial pressure 
(ICP) increases slowly to the value characterizing the resistance to CSF outflow. 
Secondly the heart rate is detectable throughout the infusion phase and lastly the pulse 
amplitude (AMP) is recordable, both features demonstrating patency of the 
ventricular drain. Both pulse amplitude (AMP) and heart rate (HR) are estimated 
using adaptive heart rate tracking spectral analysis method. 1024 point discrete power 
spectrum is calculated using 10 second intervals of sampled (100 Hz) ICP signal. 
Spectrum peak associated with a heart rate (measured using distal plethysmographic 
method) is identified manually to start the algorithm. Then it is tracked from one 
window to another during the course of the study. AMP is calculated from a power of 
first harmonic of spectral peak. During this procedure much of the fluid goes into the 
brain depending on CSF resistance to outflow possibly against sagittal sinus pressure, 
and further- down the shunt after its opening pressure is exceeded.  
 
Figure 3 demonstrates several key differences in an obstruction of ventricular drain of 
shunt system. There is no pulse waveform of ICP recorded at baseline. Primarily the 
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ICP immediately rises to the pressure level (shunt opening pressure plus abdominal 
pressure level)  above which the valve opens distally. When the distal flow is 
obstructed during the test (for example, by pressing Siphon Control Device) the 
pressure rises further and without any delay, demonstrating an isolated circuit not in 
continuation with the ventricular space. The estimated heart rate is erratic and 
inconsistent and the pulse amplitude remains almost undetectable, which further 
shows a lack of continuity between the shunt and ventricular space. Opposite to 
previous scenario (Fig. 2), during this procedure all infused fluid presumably goes 
down the shunt into the abdomen influenced by the valve resistance, opening 
pressure, length of catheter and abdominal pressure.  
 
For distal obstruction, plateau pressure reached during the study (Fig. 2) exceeds the 
level evaluated as: valve’s opening pressure plus infusion rate times hydrodynamic 
resistance of the opened valve plus certain credit for abdominal pressure (5 mm Hg in 
non-obese patients)
21,25
. 
 
CT Analysis  
The electronic records of the patients who had undergone the 499 infusion tests 
between 2007 and 2011 were screened to identify those with a CT Head scan within 
three months of the test and no surgery between the test and scan. Although ventricle 
size can change rapidly, the positioning of ventricular catheters tends to stay static in 
serial imaging, hence this large timeframe was chosen to allow for greater data 
capture whilst minimising bias from different ventricular catheters.
26
 
In total 306 CT head scans of 200 patients were analysed. No coronal or 3D 
reconstructions were used. This was to simplify the analysis and ensure ease of 
transferability so that other clinicians could assess their scans in the same way. The 
slice thickness was 5 mm per axial cut. 
Some  patients had repeated clinical presentations where shunt dysfunction was 
considered leading to repeat infusion tests and CT scans. In those cases infusion tests 
and scans classification was interpreted as independent. 
 
For this CT analysis a new classification tool was designed by the investigators to 
define the anatomical position of the proximal catheter tip. The goal was to create a 
highly specific, reproducible, easy-to-use and objective measure of location. This was 
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achieved via the creation and use of simple categories with mutually exclusive 
options, which in combination can exhaustively express all possible tip positions and 
determines relevant anatomical relationships to aid in the comparison of shunt tip 
positions. These are outlined below:  
1. Entry – Frontal OR Parietal 
2. Entry – Left OR Right 
3. Tip Position Relative to Entry – Ipsilateral OR Midline OR Contralateral 
4. Tip Position Relative to Foramen of Monro within CSF space – Anterior OR 
Posterior OR Not in ventricular space 
5. Tip Surroundings – Completely surrounded by CSF OR Completely 
surrounded Parenchyma OR Neither completely surrounded by CSF nor 
parenchyma 
6. Presence of “Collapsed Ventricles” – Yes OR No 
The classification of tip position relative to surroundings assesses the immediate 
environment of the drainage holes at the distance of 1.5 cm of the ventricular catheter. 
The word “completely” clearly divides those shunts in an optimal position (CSF) 
from those in a definitively suboptimal position (parenchyma) and groups those in 
between. This third group refers to those catheter tips which would be lying partially 
against a ventricular wall, brain parenchyma, septum pellucidum or lying within the 
foramen of Monro for example, whilst being partially surrounded by CSF.  
 
For a catheter tip to be classified as anterior to the foramen of Monro, it had to lie 
within the ventricular space anterior to a coronal plane in line with the foramen. We 
also made an additional record in the cases where the catheter tip was seen to pass 
into the Foramen of Monro, rather than remaining anterior to it. 
 
A midline classification refers to those shunt tips which lie along midline structures 
such as septum pellucidum or the third ventricle. A classification of contralateral 
position means that the tip has passed across the midline structures. ‘Collapsed 
ventricles’ refers to the radiographic evidence of narrowed or slit ventricles.  
 
Shunt tip position on CT is a surrogate marker for the actual tip, as the CT axial plane 
slices are between 5 – 10 mm generating a small margin of error. Additionally, the 
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drainage holes in the catheter are not limited to the tip and extend proximally for 
between 15 mm to 30 mm.  
General scheme of tip’s position classification and relevant examples are presented in 
Fig. 4. 
 
Reliability 
30 CT scans from our sample were selected using a random number generator and 
were then independently re-analysed by each of the first three authors using the 
classification system described above. These results were statistically compared to 
assess for inter-observer variability and thus assess the overall reliability of our 
method. 
 
Statistical Analysis 
Nominal logistical models were used to analyse the effect of the explanatory variables 
(CT classification descriptors) and their biologically relevant two-way interactions on 
the dependent variable (shunt patency or proximal occlusion detected during infusion 
test), and were subject to step-wise removal starting with the least significant 
interaction term. All rejected terms were individually reintroduced to the reduced 
model to confirm they did not improve final model performance. Analyses were 
performed in JMP 7 (SAS Institute, Marlow, UK).  
 
Results 
306 infusion studies of in vivo shunts and their corresponding CT head scans were 
analysed. The age range of the patients was 1 – 88 years with a mean age of 42 and 
the gender ratio was 2:3 (male:female). The median time between scan and infusion 
test was 1 day (interquartile range: 0 days – 9 days). Table 1 details the results of the 
analysed CT head scans as categorised by proximal shunt patency determined by 
infusion test.  
 
Out of 306 tests, 57 showed pattern of proximal blockage. The proximal patency of 
the shunt on infusion test was significantly associated with the matter it was 
surrounded by on CT scan (Table 2).  
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If the shunt was completely surrounded by brain parenchyma on CT scan, it had the 
highest likelihood of obtaining an infusion test result consistent with occlusion (33/62 
occluded = 53.22%; χ²=51.68, p<0.0001, n=306). If the shunt was completely 
surrounded by CSF it had the least likelihood of becoming occluded (2/92 occluded = 
2.17%, χ²=31.04, p<0.0001) as shown in Fig. 5. Shunts that were partially surrounded 
by both brain and CSF were significantly worse than being surrounded by CSF and 
significantly better than being surrounded by brain; with a highly significant 
difference between the two extreme groups (parenchyma versus CSF, p<0.000001). 
None of the remaining categories for classifying catheter tip position on CT were 
significantly associated with proximal patency or proximal blockage detected during 
infusion test (Table 2). Of the 249 infusion tests with results of hydrodynamic 
patency, 29 had their catheter tips surrounded by parenchyma (12%). 
 
Our model provided no evidence for frontal or parietal approach shunts to be 
significantly different in likelihood of patency, when the effect size from surrounding 
matter was removed. In addition, for the frontal shunts with catheter tips in the frontal 
horn of the lateral ventricle, further data was collected to classify the position within 
the ventricle (anterior to foramen of Monro, through foramen of Monro and abutting 
septum pellucidum). The location of these catheter tips was also not significantly 
associated with patency. 
Intraobserver agreement has been tested additionally and was assessed as high (CHI2 
= 2.65; p = 0.85 ). 
Although this was not a formal subject of the current study, but unconfirmed 
incidence of distal blockage was 72 cases (23%). Incidence of cases with patent shunt 
(normal resistance to CSF outflow) but presumably increased abdominal pressure was 
25  (8%). Totally, almost 50% of infusion tests suggested shunt malfunction and 
remaining - no evidence of malfunction.  
 
Discussion  
In approximately 19% of infusion tests in patients with clinical symptoms of 
problems potentially associated with shunt malfunction, proximal occlusion can be 
seen. Infusion test results of proximal patency were very strongly associated to the 
position of the ventricular catheter tip on CT head imaging. Patients proven to have 
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proximally blocked shunts by infusion test were highly likely to have their ventricular 
catheter tips surrounded by brain parenchyma on CT imaging. Conversely, patients in 
whom infusion tests confirmed a patent shunt were highly likely to have ventricular 
catheter tips surrounded by CSF on CT head imaging. This study shows such a 
reliable ‘hydrodynamic’ patency relationship with radiological positioning using ‘in 
vivo’ shunts.  
Distal blockage and raised abdominal pressure can be found in 32 % of cases. In total 
almost a half of symptomatic patients have shunts assessed as ‘patent’- and this is 
probably a good approximation of unnecessary shunt revisions which can be avoided 
with additional infusion test- cheap, fast and low invasive.  
 
Furthermore, this study uses a new, simple and reliable classification system to assess 
the position of ventricular catheter tips in CT head imaging, based on the prior 
hypotheses of previous works to suggest optimal catheter tip targets
8-11
. It is the 
unambiguous nature of this classification system, which has determined the effect of 
positioning factors on shunt patency. The only factor to significantly affect shunt 
patency was the type of matter immediately surrounding the catheter tip. A post hoc 
analysis showed that parietal shunts were more likely than frontal shunts to be 
blocked on infusion test, but this effect was due to the parietal shunts being less likely 
to be completely surrounded by CSF. This may be due to the anatomy of the body and 
trigone of the lateral ventricles in having smaller dimensions than the frontal horns 
and also containing choroid plexus, which has been implicated in causing shunt 
blockage. The suggestions for ‘optimal’ tip location to be anterior to the foramen of 
Monro in the ipsilateral frontal horn of the lateral ventricle
8-11
 are supported by the 
findings of this study. All catheter tips in this optimal position that were completely 
surrounded by CSF were found to be patent on infusion test; 40/40 (100%) of 
optimally positioned catheters were completely surrounded by CSF but only 52/266 
(21%) of sub-optimally positioned were completely surrounded by CSF. 
 
Only 57 infusion tests had results of hydrodynamic evidence of blockage; 19% of the 
whole group. We speculate that without this objective assessment of patency, a larger 
percentage of the group may have undergone exploratory/revision surgery on the 
basis of clinical presentation and CT findings.  
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Also of note, of the 249 infusion tests with results of hydrodynamic patency, 29 had 
their catheter tips surrounded by parenchyma (12%). It is plausible that these cases 
may be draining peri-ventricular oedema or extracellular/interstitial fluid hence their 
‘patency’, but in the context of the other results of the study we suspect such catheters 
to be of very high risk of future blockage from the solid matter surrounding the 
catheter tips.  From this reason, although the most important anatomical factor for 
shunt patency is the catheter tip being completely surrounded by CSF, it is useful to 
perform additional infusion test. The results of the test (if it is performed correctly), 
sometimes show ‘functional’ state of the shunt system, which may differ from 
‘anatomical’ arrangements.   
 
12 % of the patients had patent catheter with hydrodynamic tests but the tips of the 
catheter were surrounded by parenchyma. In our opinion, although it is not included 
in a subject of the study, those patients are of increased obstruction in a future and 
needs to be closely observed for potential onset of clinical symptoms. 
 
There is an interesting result in Table 1 that it is much more common with collapsed 
ventricles in “Blocked shunts” group (31% vs 12%). In such cases first is probably 
overdrainage, which causes ventricles to collapse and close the ventricular inlet. 
 
Clinical context 
The results of this study support the previous arguments
8-11
 of ensuring optimal 
ventricular catheter tip positioning. We propose that the success of shunt patency in 
these optimal locations is due to the higher likelihood, anatomically, of the catheter 
tip being completely surrounded by CSF. Hayhurst et al
15
 demonstrated the efficacy 
of image guidance in ensuring such optimal positioning and in view of the inherent 
difficulty in blind insertion of ventricular catheters based on surface anatomical 
landmarks alone, this work supports such methods to ensure CSF surrounds the 
catheter tip of a potentially life-long implanted device. Our results support the 
suggestion of a recent report by Yamada et al
27
 to consider early revision surgery for 
catheter tips found to be in poor positions such as intraparenchymal or along a 
ventricular wall. Our results also support the usage of medium/high pressure shunt 
valves or judiciously lowering the pressure setting on programmable valves in order 
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to avoid rapid collapse of the CSF space causing the ventricular walls to surround the 
catheter tip instead of CSF.   
 
Our results specifically validate the usage of infusion studies in routine clinical 
practice as a reliable, low risk investigation
 
to assess shunt dysfunction. Its usefulness 
for assessment shunt patency has been also confirmed by others
18,19
. Infusion study is 
a practical tool not only for testing a shunt functioning in vivo
16,17,25
 but also for 
evaluation shunt hydrodynamic performance in laboratory settings
21,28,29
. The latter 
can serve as a comparative pattern for in vivo study.  
 
Our data show a very strong statistical correlation between the results of the infusion 
test and the radiological catheter position on CT; a routinely used investigation in 
neurosurgical units for assessing patients with symptoms of shunt dysfunction. Not 
only do infusion studies provide a ‘hydrodynamic’ real time in-vivo assessment of 
shunt patency to aid the clinician in decision-making, in cases where other aspects of 
assessment are compromised their value is even more marked. For example in 
paediatric patients, patients with learning difficulties, specific neurological or 
psychiatric co-morbidities and patients with severe traumatic brain injury where a 
direct history of symptoms is not feasible or in cases where the ventricles do not alter 
dimensions on CT imaging in response to raised CSF pressure. Additionally, an 
infusion test confirming shunt patency can be a useful reassurance from clinicians to 
patients who may equate headaches to shunt blockages requiring revision surgery. 
 
Limitations 
In this study we compared location of ventricular catheter tip versus results of 
infusion study dichotomised as ventricular catheter blocked or patent. We did not 
consider distal blockage (valve itself or distal end) because for these cases imaging 
classification is not relevant. 
 
We excluded patients with grossly abnormal intracranial anatomy, cranioplasties, 
decompressive craniectomy defects and with multiple shunt catheters. Hence the 
conclusions and recommendations of this study cannot be easily generalised to those 
patient groups. We also excluded patients whose scans and infusion tests were greater 
than three months apart. This was to help ensure that the same catheters were being 
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assessed radiologically and hydrodynamically. Assessment of ventricular size in itself 
was not undertaken as this patient group was more ambiguous in the diagnosis of 
shunt dysfunction and there was not always ‘baseline’ imaging to compare against as 
many of the patients have been referred after their primary shunt surgery in other 
centres. This has also meant that data for interval from shunt insertion to infusion test 
and full etiological clinical picture at shunt insertion was not always available and 
hence not included in analysis, which may also be a source of bias.  
 
Additionally, some patients underwent multiple CT scans and infusion studies due to 
repeated presentations with symptoms of shunt dysfunction, the data from these cases 
may also be a source of bias.  
 
Occlusion of the proximal catheter often results from debris from the choroid plexus. 
The blockage by choroid plexus tissue and what is the expected CT images that 
should be seen, is not analysed as it is not possible to be determined.  
 
We reduced measurement bias by blinding researchers to the shunt status when 
assessing tip position on imaging and by using an objective classification system 
demonstrated to not have significant inter-observer variability.  
 
The design of the study has specifically not incorporated the intra-operative findings 
of those patients who went on to shunt revision. We realise that this is often the gold 
standard check of shunt patency however due to the limitations inherent with such 
data, for example lack of standardisation between intra-operative findings, missing 
data and uncontrolled intra-operative factors such as variable carbon dioxide partial 
pressure concentration affecting intracranial pressure, it was deemed that such 
analysis would be more confounding. Hence analysis was restricted to the imaging of 
catheter position and the hydrodynamic infusion test alone. However, our previous 
study performed on smaller simple size demonstrated high level of intraoperatively 
shunt blockage confirmation (90%)
16
. 
 
Aside from the clinical recommendations above, the methods in this study have 
advantages for being re-applied in future clinical shunt research. A meta-analysis of 
previous studies relied on the decision for surgical revision of a shunt as the surrogate 
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for shunt dysfunction without confirming in all cases whether intra-operative findings 
were concordant with the decision
1
; this may not be as robust as patency/blockage 
demonstrated by infusion test which may be a better surrogate in future research.  
Other classification systems have been used to categorise proximal catheter tip 
position
10,11,15,27
; our system has been developed from the anatomical concepts of 
these previous systems. However, our system is clear, easy to apply, exhaustive in 
describing all possible catheter tip positions, leaves little room for ambiguity in 
analysis and has statistical reliability to demonstrate inter-observer agreement.  Both 
paradigms for radiological and physiological assessment of shunts in vivo may prove 
useful for future research. 
 
Conclusion 
Infusion tests provide a reliable assessment of  proximal shunt patency in vivo as 
correlated with the position of the ventricular catheter on CT imaging. The most 
important anatomical factor is the catheter tip being completely surrounded by CSF. 
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Table 1. Results of CT scan analysis of shunt tip characteristics grouped by patency 
 
Table 2.  Statistical effect size of CT characteristics on proximal shunt patency 
 
*Frontal approach shunts only with catheter tips within lateral ventricles 
 
 
 
 
 CT analysis of shunt tips 
Proximally blocked shunts as 
confirmed by infusion tests  
(n = 57) 
Proximally patent shunts as 
confirmed by infusion tests  
(n = 249) 
Frontal entry 
(n = 37) 
Parietal entry 
(n = 20) 
Frontal entry  
(n = 185) 
Parietal entry 
(n = 64) 
Side of shunt 
insertion 
Left  6 4 43 15 
Right  31 16 142 49 
Location of 
shunt tip 
relative to 
entry 
Ipsilateral  8 4 67 32 
Midline 12 8 77 18 
Contralateral 17 8 41 14 
Matter 
surrounding 
shunt tip 
CSF 0 2 81 9 
Parenchyma 26 7 23 6 
Both  11 11 81 49 
State of 
ventricles 
Collapsed  15 3 24 6 
Non collapsed  22 17 161 58 
CT characteristic Degrees of freedom Chi square statistic p - value 
Matter surrounding tip (CSF/parenchyma/both) 2 63.58 <0.0001 
Entry side (left/right) 1 1.18 0.2782 
Approach (frontal/parietal) 1 2.41 0.1205 
Location of tip (ipsilateral/midline/contralateral) 2 1.10 0.5772 
Ventricle calibre (collapsed/not collapsed) 1 0.03 0.86 
*Tip anterior to foramen of Monro (Yes/No) 1 0.27 0.6034 
*Tip going through foramen of Monro (Yes/No) 1 0.72 0.3954 
*Tip abutting septum pellucidum (Yes/No) 1 0.37 0.5408 
Page 18 of 24
Acta Neurologica Scandinavica - PROOF
Acta Neurologica Scandinavica - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
PROOF
Figure legends 
 
Figure 1. Upper panel: General scheme of infusion test set-up for testing shunt 
performance in-vivo. Two 21 G needles are inserted in shunt reservoir (or pre-
chamber). Saline filled stiff manometer line connects one needle to the pressure 
transducer. Through the second needle, infusion is performed. Transducer sends 
electric signal to pressure amplifier and computer, running infusion-supporting 
software reads the signal from the output of amplifier (usual sampling frequency is 
100 Hz). 
Lower panel: Typical x-time plot of pressure recorded during study. At the baseline 
pressure remains usually stable. When infusion is started (this case: 1.5 ml/min rate- it 
is indicated by vertical bar), Pressure starts to rise gradually to reach after certain time 
( 12 minutes in this case) plateau level. Resistance to CSF outflow is calculated as 
plateau pressure minus baseline pressure, divided by infusion rate ( in this case ((32-
10 mm Hg) /1.5 ml/min= 14.6 mmHg/(ml/min). X-axis: time in format: date/ 
hours/mins. 
 
Figure 2. Infusion test showing the waveforms for a functional shunt. ICP- mean ICP, 
HR- heart rate, AMP- pulse amplitude (first harmonic) of pulsatile waveform. This is 
a case with patent ventricular inlet. Pressure rises gradually to reach the plateau, pulse 
amplitude changes proportionally to mean ICP, heart rate is followed continuously. 
‘Critical threshold’ is a pressure level, calculated for specific type of shunt (Strata, 
performance level 1), as infusion rate time shunt’s hydrodynamic resistance plus 
opening pressure plus credit for abdominal pressure ( 5 mm Hg). In this case plateau 
pressure did not exceed ‘critical threshold’, which indicates that the shunt is patent 
distally. 
 
Figure 3.  Infusion test showing the waveforms produced in proximal obstruction. 
Pressure in shunt prechamber is arbitrary, without pulse waveform (AMP almost 
zero) and erratic (non-continuous) detection of the heart rate. After start of infusion, 
pressure rises almost immediately (no delay, means that the compliance of the system 
is much lower than in Figure 2) to the value above opening level for the shunt plus 
abdominal pressure. During infusion, if this is possible (it is possible in shunts like a 
Strata or Delta - with distal membrane Siphon-Control Device) distal occlusions are 
performed. Pressure rises immediately to very high values and decreases immediately 
after release of the occlusion. 
 
 
Figure 4. Upper panel: Schematic diagram of the possible positions for the 
ventricular catheter tip for a right frontal shunt. 
Lower left: Axial CT slice showing right frontal entry ventricular catheter with tip in 
ipsilateral, non-collapsed ventricle, anterior to the foramen of Monro and completely 
surrounded by CSF 
Lower right: Axial CT slice showing a right frontal entry shunt with tip in 
contralateral hemisphere and completely surrounded by parenchyma. The ventricles 
are not collapsed.  
  
Figure 5. Bar plot of infusion test patency by matter surrounding catheter tip. Black – 
percent of infusion tests indicating ventricular block. Light grey –  percent of tests 
indicating patent or partially patent ventricular drain. 
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Upper panel: General scheme of infusion test set-up for testing shunt performance in-vivo. Two 21 G 
needles are inserted in shunt reservoir (or pre-chamber). Saline filled stiff manometer line connects one 
needle to the pressure transducer. Through the second needle, infusion is performed. Transducer sends 
electric signal to pressure amplifier and computer, running infusion-supporting software reads the signal 
from the output of amplifier (usual sampling frequency is 100 Hz).  
Lower panel: Typical x-time plot of pressure recorded during study. At the baseline pressure remains usually 
stable. When infusion is started (this case: 1.5 ml/min rate- it is indicated by vertical bar), Pressure starts to 
rise gradually to reach after certain time ( 12 minutes in this case) plateau level. Resistance to CSF outflow 
is calculated as plateau pressure minus baseline pressure, divided by infusion rate ( in this case ((32-10 mm 
Hg) /1.5 ml/min= 14.6 mmHg/(ml/min). X-axis: time in format: date/ hours/mins.  
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Infusion test showing the waveforms for a functional shunt. ICP- mean ICP, HR- heart rate, AMP- pulse 
amplitude (first harmonic) of pulsatile waveform. This is a case with patent ventricular inlet. Pressure rises 
gradually to reach the plateau, pulse amplitude changes proportionally to mean ICP, heart rate is followed 
continuously. ‘Critical threshold’ is a pressure level, calculated for specific type of shunt (Strata, 
performance level 1), as infusion rate time shunt’s hydrodynamic resistance plus opening pressure plus 
credit for abdominal pressure ( 5 mm Hg). In this case plateau pressure did not exceed ‘critical threshold’, 
which indicates that the shunt is patent distally.  
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Infusion test showing the waveforms produced in proximal obstruction. Pressure in shunt prechamber is 
arbitrary, without pulse waveform (AMP almost zero) and erratic (non-continuous) detection of the heart 
rate. After start of infusion, pressure rises almost immediately (no delay, means that the compliance of the 
system is much lower than in Figure 2) to the value above opening level for the shunt plus abdominal 
pressure. During infusion, if this is possible (it is possible in shunts like a Strata or Delta - with distal 
membrane Siphon-Control Device) distal occlusions are performed. Pressure rises immediately to very high 
values and decreases immediately after release of the occlusion.  
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Upper panel: Schematic diagram of the possible positions for the ventricular catheter tip for a right frontal 
shunt.  
Lower left: Axial CT slice showing right frontal entry ventricular catheter with tip in ipsilateral, non-collapsed 
ventricle, anterior to the foramen of Monro and completely surrounded by CSF  
Lower right: Axial CT slice showing a right frontal entry shunt with tip in contralateral hemisphere and 
completely surrounded by parenchyma. The ventricles are not collapsed.  
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Bar plot of infusion test patency by matter surrounding catheter tip. Black – percent of infusion tests 
indicating ventricular block. Light grey –  percent of tests indicating patent or partially patent ventricular 
drain.  
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